Angiotensin type 2 receptor antagonism as a new target to manage gout. (2022)
Attributed to:
HCN ion channels and pain
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10787-022-01076-x
PubMed Identifier: 36173505
Publication URI: http://europepmc.org/abstract/MED/36173505
Type: Journal Article/Review
Volume: 30
Parent Publication: Inflammopharmacology
Issue: 6
ISSN: 0925-4692